Mark Veleba
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
- Microbiology top 10%
- Antimicrobial Peptides and Activities
Papers in
-
- Antibiotic Resistance in Bacteria 5
-
- Antimicrobial Peptides and Activities 1
- Co-authors
- Thamarai Schneiders (4 shared papers)Kimberly A. Kline (8 shared papers)Shyamasree De Majumdar (2 shared papers)Gerardo González (1 shared paper)Paul Higgins (1 shared paper)Harald Seifert (1 shared paper)Séamus Fanning (1 shared paper)Sarah Finn (1 shared paper)
- Journals
- Antimicrobial Agents and Chemotherapy (3 papers)Science Advances (2 papers)Frontiers in Cell and Developmental Biology (1 paper)PLoS Genetics (1 paper)npj Biofilms and Microbiomes (1 paper)
- Partner nations
- SingaporeSwitzerlandUnited Kingdom
In The Last Decade
Mark Veleba
11 papers receiving 419 citations
Peers
Comparison fields: 5 of 42
- Molecular Medicine 240
- Microbiology 43
- Periodontics 35
- Endocrinology 14
- Rehabilitation 14
Countries citing papers authored by Mark Veleba
This map shows the geographic impact of Mark Veleba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Veleba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Veleba more than expected).
Fields of papers citing papers by Mark Veleba
This network shows the impact of papers produced by Mark Veleba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Veleba. The network helps show where Mark Veleba may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Veleba, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 102 | |
| 2 | 2016 | 61 | |
| 3 | 2013 | 54 | |
| 4 | 2013 | 53 | |
| 5 | 2012 | 48 | |
| 6 | 2021 | 42 | |
| 7 | 2023 | 22 | |
| 8 | 2024 | 18 | |
| 9 | 2021 | 17 | |
| 10 | 2024 | 5 | |
| 11 | 2025 | 5 | |
| 12 | 2026 | 0 | |
| 13 | 2026 | 0 |
About Mark Veleba
Mark Veleba is a scholar working on Molecular Medicine, Microbiology, Rehabilitation, Infectious Diseases and Endocrinology, having authored 13 papers that have together received 427 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (5 papers), Bacterial biofilms and quorum sensing (2 papers), Wound Healing and Treatments (2 papers), Antimicrobial Peptides and Activities (1 paper), Antifungal resistance and susceptibility (1 paper), RNA and protein synthesis mechanisms (1 paper), Gut microbiota and health (1 paper) and Antimicrobial Resistance in Staphylococcus (1 paper). The work is most often cited by research in Molecular Medicine (240 citations), Microbiology (43 citations), Periodontics (35 citations), Endocrinology (14 citations) and Rehabilitation (14 citations). Mark Veleba has collaborated with scholars based in Singapore, Switzerland and United Kingdom. Frequent co-authors include Thamarai Schneiders, Kimberly A. Kline, Shyamasree De Majumdar, Gerardo González, Paul Higgins, Harald Seifert, Séamus Fanning, Sarah Finn, Michael Hornsey and Neil Woodford. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Science Advances, Frontiers in Cell and Developmental Biology, PLoS Genetics and npj Biofilms and Microbiomes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.